Milan, Italy based Sorin Group has announced CE marking of its new PARADYM RF line of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-D). The new devices are compatible with Sorin’s SMARTVIEW system, which lets doctors remotely monitor patients, and also incorporate the SafeR and Parad+ algorithms to prevent the delivery of unnecessary shocks.
From the press release:
PARADYM RF™ CRT-D and ICDs are designed to provide patients with the optimal combination of thinness, high power and longevity. Utilizing state-of-the-art battery and capacitor technology and an innovative remote monitoring design featuring high speed data transfer and monitor-initiated connection, the PARADYM™ RF CRT-D and ICD devices deliver 37J of energy with longevity over 6 years and 9 years respectively in an 11mm thin device.
The PARADYM™ RF family includes Sorin’s proprietary SafeR™ and Parad™+ algorithms that automatically adjust to each individual patient to minimize right ventricular pacing and inappropriate shocks.
The PARADYM™ RF CRT-D also features a new programming option to electronically reprogram the device to avoid phrenic nerve stimulation, a common side effect of resynchronization therapy. In addition, PARADYM™ RF CRT-Ds include Sorin’s exclusive Brady-Tachy Overlap (BTO™) algorithm that provides pacing therapy during exercise while maintaining the ability to detect and treat slow ventricular arrhythmias.
Press release: Sorin Group Receives CE Mark Approval for PARADYM™ RF ICDS And CRT-D
Product pages: Parad/Parad+; SafeR
